{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:58:14Z","timestamp":1792004294766,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL 1TR002541"],"award-info":[{"award-number":["UL 1TR002541"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.preghy.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T20:58:33Z","timestamp":1555102713000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy"],"prefix":"10.1016","volume":"16","author":[{"given":"Kristin D.","family":"Gerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2818-4572","authenticated-orcid":false,"given":"Samantha","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam J.","family":"Haviland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele R.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa H.","family":"Spiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.preghy.2019.04.002_b0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/48.3.421","article-title":"Predominant hematopoietic origin of cell-free dna in plasma and serum after sex-mismatched bone marrow transplantation","volume":"48","author":"Lui","year":"2002","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.preghy.2019.04.002_b0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pd.1700","article-title":"Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast","volume":"27","author":"Alberry","year":"2007","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.preghy.2019.04.002_b0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","article-title":"Size Distributions of Maternal and Fetal DNA in Maternal Plasma","volume":"50","author":"Chan","year":"2004","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.preghy.2019.04.002_b0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1373\/clinchem.2010.144188","article-title":"Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing","volume":"56","author":"Fan","year":"2010","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.preghy.2019.04.002_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11\u201313 weeks\u2019 gestation: Relation to maternal and fetal characteristics","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2019.04.002_b0030","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000001051","article-title":"Cell- free DNA Screening for Fetal Aneuploidy","volume":"126","author":"ACOG","year":"2015","journal-title":"Obs. Gynecol."},{"issue":"11","key":"10.1016\/j.preghy.2019.04.002_b0035","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/1933719115584445","article-title":"Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma","volume":"22","author":"Zhou","year":"2015","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.preghy.2019.04.002_b0040","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pd.4668","article-title":"The influence of low molecular weight heparin medication on plasma DNA in pregnant women","volume":"35","author":"Gr\u00f6mminger","year":"2015","journal-title":"Prenat. Diagn."},{"issue":"17","key":"10.1016\/j.preghy.2019.04.002_b0045","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA Analysis for Noninvasive Examination of Trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N. Engl. J. Med. [Internet]."},{"key":"10.1016\/j.preghy.2019.04.002_b0050","article-title":"Obesity and cell-free DNA \u201cno calls\u201d: is there an optimal gestational age at time of sampling?","author":"Livergood","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0055","doi-asserted-by":"crossref","DOI":"10.1002\/pd.5152","article-title":"The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction","author":"Burns","year":"2017","journal-title":"Prenat. Diagn. [Internet]."},{"issue":"1","key":"10.1016\/j.preghy.2019.04.002_b0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/302205","article-title":"Rapid clearance of fetal DNA from maternal plasma","volume":"64","author":"Lo","year":"1999","journal-title":"Am. J. Hum. Genet. [Internet]."},{"issue":"3","key":"10.1016\/j.preghy.2019.04.002_b0065","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1073\/pnas.76.3.1453","article-title":"Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting","volume":"76","author":"Herzenberg","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8676","key":"10.1016\/j.preghy.2019.04.002_b0070","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(89)91969-7","article-title":"Prenatal sex determination by DNA amplification from maternal peripheral blood","volume":"2","author":"Lo","year":"1989","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.preghy.2019.04.002_b0075","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/pd.1970141308","article-title":"Isolating fetal cells in maternal circulation for prenatal diagnosis","volume":"14","author":"Simpson","year":"1994","journal-title":"Prenat. Diagn."},{"issue":"11","key":"10.1016\/j.preghy.2019.04.002_b0080","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1182\/blood.V88.11.4390.bloodjournal88114390","article-title":"Two-way cell traffic between mother and fetus: biologic and clinical implications","volume":"88","author":"Lo","year":"1996","journal-title":"Blood [Internet]."},{"issue":"9076","key":"10.1016\/j.preghy.2019.04.002_b0085","first-page":"485","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet[Internet]."},{"issue":"6","key":"10.1016\/j.preghy.2019.04.002_b0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pd.2730","article-title":"Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011","volume":"31","author":"Benn","year":"2011","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.preghy.2019.04.002_b0095","article-title":"545: Noninvasive prenatal testing for fetal aneuploidy","author":"Committee opinion no","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0100","doi-asserted-by":"crossref","DOI":"10.1007\/s10897-012-9545-3","article-title":"NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy","author":"Wilson","year":"2013","journal-title":"J. Genet. Counsel."},{"key":"10.1016\/j.preghy.2019.04.002_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2013.11.014","article-title":"Review: Cell-free fetal DNA in the maternal circulation as an indication of placental health and disease","volume":"Vol. 35","author":"Taglauer","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2019.04.002_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2010.06.018","article-title":"Cell-free nucleic acids as potential markers for preeclampsia","author":"Hahn","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2019.04.002_b0115","article-title":"Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. BJOG An Int","author":"Knight","year":"1998","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0120","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.2001.tb03873.x","article-title":"Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities","author":"Smid","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.preghy.2019.04.002_b0125","doi-asserted-by":"crossref","DOI":"10.1067\/mob.2001.109594","article-title":"Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia","author":"Zhong","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/pd.863","article-title":"Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood","author":"Farina","year":"2004","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.preghy.2019.04.002_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.07.063","article-title":"Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction","author":"Alberry","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0140","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpt187","article-title":"Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome","author":"Miranda","year":"2013","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.preghy.2019.04.002_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/j.1447-0756.2012.02011.x","article-title":"Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies","author":"Zeybek","year":"2013","journal-title":"J Obs. Gynaecol. Res."},{"key":"10.1016\/j.preghy.2019.04.002_b0150","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-10-120","article-title":"Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia","author":"Lazar","year":"2009","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.preghy.2019.04.002_b0155","doi-asserted-by":"crossref","DOI":"10.1159\/000236355","article-title":"Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction","author":"Al Nakib","year":"2009","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.preghy.2019.04.002_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2004.12.023","article-title":"High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery","author":"Farina","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.02.009","article-title":"Cell-free DNA fetal fraction and preterm birth","author":"Dugoff","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/uog.14671","article-title":"Maternal plasma cell-free DNA in the prediction of pre-eclampsia","author":"Rolnik","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/uog.14666","article-title":"Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery","author":"Quezada","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0180","article-title":"Association of Fetal Fraction of Cell-Free DNA and Hypertensive Disorders of Pregnancy","author":"Bender","year":"2018","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.preghy.2019.04.002_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/pd.4779","article-title":"Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing","author":"Krishna","year":"2016","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.preghy.2019.04.002_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/uog.18993","article-title":"Association between fetal fraction on cell-free DNA testing and first trimester markers for pre-eclampsia","author":"Rolnik","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejogrb.2018.03.048","article-title":"Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy","author":"Suzumori","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2019.04.002_b0200","article-title":"Guidelines: Hypertension in pregnancy. American College of Obstetricians and Gynecologists","author":"ACOG","year":"2013","journal-title":"Task Force on Hypertension in Pregnancy"},{"key":"10.1016\/j.preghy.2019.04.002_b0205","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","author":"Brown","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.preghy.2019.04.002_b0210","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.preghy.2019.04.002_b0215","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwh090","article-title":"A Modified Poisson Regression Approach to Prospective Studies with Binary Data","author":"Zou","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.preghy.2019.04.002_b0220","doi-asserted-by":"crossref","DOI":"10.1159\/000448707","article-title":"Cell-Free Placental DNA in Maternal Plasma in Relation to Placental Health and Function","author":"Manokhina","year":"2017","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.preghy.2019.04.002_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/pd.4195","article-title":"Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study","author":"Samuel","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.preghy.2019.04.002_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2004.12.015","article-title":"Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA","author":"Wataganara","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2019.04.002_b0235","doi-asserted-by":"crossref","DOI":"10.1097\/01.ogx.0000451481.18231.1b","article-title":"DNA sequencing versus standard prenatal aneuploidy screening","author":"Bianchi","year":"2014","journal-title":"Obstet. Gynecol. Surv."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778919300017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778919300017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:51:55Z","timestamp":1761897115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778919300017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":47,"alternative-id":["S2210778919300017"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2019.04.002","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}